WILMINGTON, N.C. (April 21, 2014) – Pharmaceutical Product Development, LLC (PPD) today announced the addition of Bhooshi De Silva as senior vice president of corporate development and strategy to its executive leadership team. De Silva will focus on key strategic initiatives vital to supporting PPD’s growth and client success, including corporate development, strategy and mergers and acquisitions.
“Bhooshi’s vision and expertise will be invaluable in our efforts to grow our business and successfully meet the evolving needs of our clients,” said David Simmons, PPD’s chairman and chief executive officer. “He comes to PPD well-prepared to help us navigate the challenges of the changing biopharmaceutical landscape, while developing and executing a strategy for our company’s continued success.”
With 15 years of experience in the biopharmaceutical industry, De Silva brings significant leadership expertise. He started his career at Pfizer, holding roles across the research and development and commercial organizations in portfolio management, strategy and operations. His responsibilities included overseeing the development and strengthening of analytical frameworks and decision-making processes.
In 2009, De Silva was named vice president of business development evaluation and strategy, leading a team in the evaluation of licensing, acquisitions and corporate strategic initiatives for Pfizer. Most recently, he served as head of business development, corporate strategy and international teams at Optimer Pharmaceuticals.
De Silva holds degrees in finance, economics and engineering from Stanford University, London School of Economics and Imperial College of Science & Technology in London.
About PPD
PPD is a leading global contract research organization providing drug discovery, development, lifecycle management and laboratory services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 46 countries and more than 13,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a commitment to quality to help clients and partners accelerate the delivery of safe and effective therapeutics and maximize the returns on their R&D investments.
Contacts
Media:
Lee Kennedy
+1 919 456 5350
[email protected]
Investors:
Luke Heagle
+1 910 558 7585
[email protected]